Pigment Cell & Melanoma Research

Papers
(The TQCC of Pigment Cell & Melanoma Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease61
An update on Vitiligo pathogenesis59
The enigma and challenges of vitiligo pathophysiology and treatment49
Management of hyperpigmentation: Current treatments and emerging therapies41
Rab GTPases: Key players in melanosome biogenesis, transport, and transfer38
Chemical and biochemical control of skin pigmentation with special emphasis on mixed melanogenesis38
The evolution of human skin pigmentation involved the interactions of genetic, environmental, and cultural variables31
Nicotinamide N‐methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines30
Participation of keratinocyte‐ and fibroblast‐derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders28
The role of ferroptosis in melanoma27
Alterations of the pigmentation system in the aging process26
Genetics of non‐syndromic and syndromic oculocutaneous albinism in human and mouse25
The α‐melanocyte‐stimulating hormone/melanocortin‐1 receptor interaction: A driver of pleiotropic effects beyond pigmentation24
The fate of melanocyte: Mechanisms of cell death in vitiligo23
The role of technology in melanoma screening and diagnosis23
Strategies in DNA vaccine for melanoma cancer22
The tumour immune landscape and its implications in cutaneous melanoma22
First‐line atezolizumab monotherapy in patients with advanced BRAFV600 wild‐type melanoma22
The structure and function of the mouse tyrosinase locus21
Cyclic adenosine monophosphate (cAMP) signaling in melanocyte pigmentation and melanomagenesis21
Identification of melanoma‐specific exosomal miRNAs as the potential biomarker for canine oral melanoma20
Emerging strategies to treat rare and intractable subtypes of melanoma20
NRF2‐dependent stress defense in tumor antioxidant control and immune evasion19
The effect of aging and antioxidants on photoreactivity and phototoxicity of human melanosomes: An in vitro study18
Dark cyclobutane pyrimidine dimers are formed in the epidermis of Fitzpatrick skin types I/II and VI in vivo after exposure to solar‐simulated radiation16
Support for increased cardiovascular risk in non‐segmental vitiligo among Egyptians: A hospital‐based, case–control study16
Novel three‐way complex rearrangement of TRPM1‐PUM1LCK in a case of agminated Spitz nevi arising in a giant congenital hyperpigmented macule15
Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells15
HPS11 and OCA8: Two new types of albinism associated with mutations in BLOC1S5 and DCT genes15
Current landscape of Oculocutaneous Albinism in Japan14
The PI3K pathway induced by αMSH exerts a negative feedback on melanogenesis and contributes to the release of pigment14
Vitiligo: Translational research and effective therapeutic strategies13
Artificial intelligence and melanoma: A comprehensive review of clinical, dermoscopic, and histologic applications13
Human TYRP1: Two functions for a single gene?13
Dhh‐expressing Schwann cell precursors contribute to skin and cochlear melanocytes, but not to vestibular melanocytes13
A Focused review on the pathophysiology of post‐inflammatory hyperpigmentation13
Premature senescence in human melanocytes after exposure to solar UVR: An exosome and UV‐miRNA connection12
Altered expression of ferroptosis markers and iron metabolism reveals a potential role of ferroptosis in vitiligo12
The unfolded protein and integrated stress response in melanoma and vitiligo12
User guide to MiT‐TFE isoforms and post‐translational modifications12
Molecular characterization of SLC24A5 variants and evaluation of Nitisinone treatment efficacy in a zebrafish model of OCA612
The AMP‐dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma12
Speed rate (SR) as a new dynamic index of melanoma behavior11
Endothelin signaling promotes melanoma tumorigenesis driven by constitutively active GNAQ11
RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological features11
Immunotherapy for older patients with melanoma: From darkness to light?11
The MITF regulatory network in melanoma11
Reconstructed human pigmented skin/epidermis models achieve epidermal pigmentation through melanocore transfer10
The role of melanocytes in the human choroidal microenvironment and inflammation: Insights from the transcriptome10
YAP facilitates melanoma migration through regulation of actin‐related protein 2/3 complex subunit 5 (ARPC5)10
Phenotypic plasticity of melanocytes derived from human adult skin10
Non‐invasive optical biopsy by multiphoton microscopy identifies the live morphology of common melanocytic nevi10
CD147 regulates melanoma metastasis via the NFAT1‐MMP‐9 pathway9
New insights into the pathogenesis of Hermansky–Pudlak syndrome9
Analysis of CRISPR‐Cas9 screens identifies genetic dependencies in melanoma9
Genetic variants and mutational spectrum of Chinese Hermansky–Pudlak syndrome patients9
Multiple desmoplastic Spitz nevi with BRAF fusions in a patient with ring chromosome 7 syndrome9
Five novel mutations in SASH1 contribute to lentiginous phenotypes in Japanese families9
Drosophila yellow‐h encodes dopaminechrome tautomerase: A new enzyme in the eumelanin biosynthetic pathway9
Melanin‐concentrating hormone like and somatolactin. A teleost‐specific hypothalamic‐hypophyseal axis system linking physiological and morphological pigmentation9
Acral lentiginous melanoma—Population, treatment, and survival using the NCDB from 2004 to 20158
A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma8
Antihypertensives and melanoma: An updated review8
The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma7
Transcriptomic analysis and ednrb expression in cochlear intermediate cells reveal developmental differences between inner ear and skin melanocytes7
Recurrent co‐alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis7
Volar location and degree of pigmentation are associated with poor survival and first metastasis pattern in acral melanoma7
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation7
The delicate relation between melanocytes and skin immunity: A game of hide and seek7
Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma7
Consideration of possible effects of vitamin D on established cancer, with reference to malignant melanoma7
Germline loss‐of‐function variants in MBD4 are rare in Finnish patients with uveal melanoma7
The impaired unfolded protein‐premelanosome protein and transient receptor potential channels‐autophagy axes in apoptotic melanocytes in vitiligo7
Heme oxygenase promotes B‐Raf‐dependent melanosphere formation7
Establishment of a mouse model for post‐inflammatory hyperpigmentation7
A novel BLOC1S5‐related HPS‐11 patient and zebrafish with bloc1s5 disruption6
Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma6
Investigating DNA methylation as a potential mediator between pigmentation genes, pigmentary traits and skin cancer6
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study6
The feather pattern autosomal barring in chicken is strongly associated with segregation at the MC1R locus6
Induced pluripotent stem cell‐derived myeloid cells expressing OX40 ligand amplify antigen‐specific T cells in advanced melanoma6
Connexins in melanoma: Potential role of Cx46 in its aggressiveness6
Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy6
Instant isolation of highly purified human melanocytes from freshly prepared epidermal cell suspensions6
Topical RT1640 treatment effectively reverses gray hair and stem cell loss in a mouse model of radiation‐induced canities6
0.022422075271606